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Highlights 
 The aim of this study was to investigate a range of PAMAM dendrimer generations against 
Gram-positive and Gram-negative skin pathogens and to determine any differences in 
antimicrobial potency for different generations, characterising how differences in 
physicochemical properties influence antimicrobial efficacy.  
 The results of this study indicate that the antimicrobial efficacy of native PAMAM 
dendrimers is dependent on generation, concentration and terminal functionalities. 
 There was a strong correlation between membrane disruption and the determined biocidal 
activity, making it a key contributing mechanism of action.  
 Selection of the type of PAMAM dendrimer is important as their inherent antimicrobial 
efficacy varies according to their individual physicochemical properties.  
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ABSTRACT  
The aim of this study was to investigate a range of poly(amidoamine) (PAMAM) dendrimer 
generations against Gram-positive and Gram-negative skin pathogens and to determine any 
differences in antimicrobial potency for different generations, characterising how differences in 
physicochemical properties influence antimicrobial efficacy. A range of tests were carried out, 
including viable count assays to determine IC50 values for each dendrimer, membrane integrity 
studies and an inner membrane permeabilisation assay. This is supported by scanning electron 
microscopy imaging of the interactions observed between dendrimers and bacteria. The results of 
this study indicate that the antimicrobial efficacy of native PAMAM dendrimers is dependent on 
generation, concentration and terminal functionalities, for example the MIC50 (g/mL) against S. 
aureus was between 26.77 for the G2-PAMAM-NH2 dendrimer and 2.881 for the G5-PAMAM-NH2 
dendrimer. There was a strong correlation between membrane disruption and the determined 
biocidal activity, making it a key contributing mechanism of action. This study demonstrates that 
selection of the type of PAMAM dendrimer is important as their inherent antimicrobial efficacy 
varies according to their individual physicochemical properties. This understanding may pave the 
way for the development of enhanced dendrimer-based antimicrobial formulations and drug 
delivery systems.  
 
Key words: Polyamidoamine dendrimers; Skin; Biocide; Novel antiseptic; Antimicrobial 
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1. Introduction 
 
The skin is normally colonised by a diverse range of commensal microorganisms; when a patient’s 
immune system is compromised or the skin barrier is impaired these microorganisms may then elicit 
an infection. Many such infections arise from the patient’s own microbial flora, with the most 
prominent pathogen being Staphylococcus aureus. S. aureus typically resides within the anterior 
nares and perineum1 and those patients colonised on hospital admission are at a greater risk of 
developing surgical-site incision infections. It has also been shown to spread epidemically between 
patients and can be transferred from staff to patients, and vice versa2.  
 
Strategies in synthetic chemistry aimed at developing improved antimicrobials have traditionally 
focused on identifying orally bioavailable small drug molecules, often utilising high-throughput 
screening methods3, an approach that has not yet translated into the availability of novel antibiotics 
in the clinic, particularly in light of growing microbial resistance. Biological targets, such as bacterial 
cell membranes, consist of macromolecules that rely on polyvalent interactions in their binding4. 
Most biological targets are of a nano-scale (1-100 nm) and therefore polyvalent macromolecules of a 
similar size may have increased biological efficacy when compared to small-molecule drugs due to a 
match in scale and multivalent binding3. For example, silver nanoparticles with a 1 to 10 nm size 
range were shown to have a greater direct interaction with bacteria than particles >10 nm in 
diameter5, and silver complexes of PAMAM dendrimers have been shown to be effective against S. 
aureus, E. coli and Pseudomonas aeruginosa in vitro6.  
 
Polyamidoamine (PAMAM) dendrimers have become the most widely investigated dendrimers for a 
range of biomedical applications7-9. Their highly branched and globular nature gives them unique 
properties which enable them to function as a multivalent biocide or a nano-scale platform for 
antimicrobial drug delivery10. The uniform branching of dendrimers provides a large surface-area-to-
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volume ratio, enabling high reactivity with microorganisms in vivo11. The highly localized and dense 
occurrence of functional groups on the dendrimer’s surface can be tailored for antimicrobial efficacy 
or for the conjugation of targeting ligands to a variety of a microorganism’s receptors12,13. 
 
The antimicrobial properties of unmodified PAMAM dendrimers against ocular pathogens was 
explored by Calbaretta and co-workers14. They found that the amine terminated G5-PAMAM 
dendrimer was toxic to P. aeruginosa with an MIC50 of 1.5 ± 0.1 μg/mL, but less so for S. aureus (20.8 
± 3.4 μg/mL). It was demonstrated that a partial coating of the amine groups with (PEG) reduced the 
toxicity of the G5-PAMAM against human corneal epithelial cells whilst retaining high toxicity against 
P. aeruginosa with a MIC50 of 0.9 ± 0.1 μg/mL. PEGylation (polyethylene glycol) of the G5-PAMAM 
resulted in a further decrease in efficacy against the Gram positive S. aureus14. Further, they 
separately reported that, even though G5-PAMAM-NH2 has a greater localization of amines at its 
surface compared to G3-PAMAM, the potency was not increased15.  
 
Thus, the aim of this study was to investigate a range of PAMAM dendrimer generations, including 
amine- and carboxyl-terminated dendrimers, against Gram-positive and Gram-negative skin 
pathogens and to determine any differences in antimicrobial potency for different generations, and 
thus characterise how differences in molecular weights and surface charge affects antimicrobial 
efficacy.  
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2. Materials and Methods 
 
2.1. Microdilution broth with viable count assay to determine inhibitory concentration (MIC50) 
Bacterial culture grade petri dishes, universals and pipette tips were all purchased from Startstedt 
(Leicester, UK). Bacterial growth medium, Mueller-Hinton agar (MHA) and Mueller-Hinton broth 
(MHB) were obtained from Oxoid (Basingstoke, UK). The cation content (Mg2+ and Ca2+) was adjusted 
in line with recommendations from the Clinical and Laboratory Standards Institute (CLSI)16. All salts 
used in diluents or media were reagent grade and purchased from Fisher (Loughborough, UK). S. 
aureus (ATCC 11832) and E. coli (ATCC 8277) were plated out on respective cation-adjusted MHA 
using a streak plate method to ensure growth of single colonies. The inoculated MHA plates were 
inverted and incubated at 37°C ± 1°C for 18-24 hours in aerobic conditions. After incubation, 3-4 
single colonies were swabbed with a sterile loop and used to inoculate 10 ml of cation adjusted MHB 
which was then incubated at 37°C ± 1°C for 18 hours. The dense overnight inoculum was then 
diluted to an absorbance of 0.140 using a UV-Vis spectrophotometer (Hitachi, U1-900, Berkshire, UK) 
to achieve an inoculum density of ~107 cells/mL. The bacterial cell density at an absorbance of 0.140 
was confirmed by diluting the bacteria and counting the cells using a haemocytometer. The 
inoculum was then further diluted in cation adjusted MHB to achieve a test inoculum of 1x105 
cells/mL. 
 
PAMAM dendrimers (generations G2-G5; Sigma Aldrich, Dorset, UK) at varying concentrations in 
methanol (MeOH) were prepared at concentrations ranging from 500-1 μg/mL in ultrapure sterile 
water. Each PAMAM dendrimer concentration was tested in triplicate and 50 μL of each solution was 
plated onto a sterile 96-well plate. 50 μL of the inoculum was added to each well, except for 3 wells 
with cation-adjusted MHB and sterile water only as a sterility control.  A growth control was tested 
in parallel without the addition of PAMAM dendrimer and a positive control of gentamicin 1 mg/mL 
was included. The 96-well plate was then incubated at 37°C ± 1°C for 2 hours and shaken at 200 rpm. 
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After a two hour incubation period, each well (excluding sterility control) was serially diluted 1:10 in 
cation-adjusted MHB to achieve a range of dilutions down to 1:100,000 and then further agitated 
using a sterile pipette tip. 50 μL of each dilution was plated onto a petri dish using the pour plate 
method with the addition of 25 mL of molten MHA at 45°C. The plates were then inverted and 
incubated for 18-24 h at 37°C ± 1°C in aerobic conditions. Post incubation, bacterial colonies on each 
plate were manually counted using a click counter. The dilutions where 30-300 colony forming units 
(CFUs) had grown for each growth control or PAMAM test concentration were selected. Each test 
concentration was tested in triplicate and the inhibition percentage was calculated using Equation 
2.1. The data was then plotted as a graph of log (inhibitor) versus normalized response to determine 
the MIC50 (Equation 1) usingGraphPad Prism
®version 5 (San Diego, USA). 
 
                             (
             
                    
)       
Equation 1 Inhibition percentage calculation 
 
  
   
                              
 
Equation 2 Calculation of MIC50concentration 
 The log (dose) response curve follows a sigmoidal curve and the data was normalized 
to the growth control as 100%. The normalized model forces the curve from 0% to 100%. This is ideal 
for the calculation of the MIC50 i.e. the concentration at 50% growth inhibition. This model also does 
not assume a standard hill slope of 1.0 but fits the hill slope from the data therefore it is a variable 
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slope model that is ideal when there are many data points. The broth microdilution assays to 
calculate the MIC50 concentrations were ran as n=9 therefore this model was ideal. 
 
 
2.2. Membrane integrity study 
The membrane integrity study was modified from the method outlined in Chen and Cooper.27 S. 
aureus (ATCC 11832), S. epidermidis (ATCC 12228) and E. coli (ATCC 8277) were plated on tryptone 
soya agar (TSA) plates using a streak method. The inoculated plates were inverted and incubated at 
37°C ± 1°C for 18-24 hours in aerobic conditions. After the incubation period 2-3 single colonies were 
removed using a sterile loop and used to inoculate tryptone soya broth (TSB). The inoculated TSB 
was then incubated for 18 h at 37°C ± 1°C. Post-incubation period the inoculated TSB was then 
centrifuged at 1000 x g for 10 mins to harvest the bacterial cells, with the resultant pellet 
resuspended in 1x phosphate-buffered saline (PBS, pH 7.4). This was centrifuged (as above) and the 
supernatant discarded. The pellet was washed and resuspended in PBS and the absorbance was 
adjusted to 0.7 at 420 nm to dilute the cells to a final test suspension. A 3 mL aliquot of the final 
bacterial inoculum was added to a 3 mL aliquot of the PAMAM dendrimer solution at a 
concentration of 10 x the calculated MIC50 for each respective PAMAM dendrimer generation. At 
different time points (20, 40, 60, and 120 min) a 1.5 mL aliquot of the sample was removed and 
immediately syringe-filtered using a 0.22 μm syringe filter (Millipore MCE sterile 33 mm filter, 
Watford, UK). The particulate-free supernatant was analysed at 260 nm by UV spectrometry 
(Hitachi, U1-900, Berkshire, UK), with the absorbance being plotted against each time point. 
 
2.3. Inner membrane permeabilisation assay 
Inner membrane permeabilisation was determined by the release of cytoplasmic β-galactosidase 
from E. coli into the culture medium in a method modified from Je and Kim (2006)28. E. coli was 
cultured, harvested and washed and re-suspended in 0.5% NaCl. E. coli was re-suspended at an 
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absorbance of 0.6 at 420 nm and 100 μL of the test inoculum was transferred into each well of a 96-
well plate. 100 μL of PAMAM dendrimer (generations 2, 3, 3.5, 4 and 5 at concentrations of 0.1, 1, 5, 
10, 25 and 50 μg/mL was  added to each well. Also, 10 μL of a 30 mM ortho-nitrophenyl-β-
galactoside (ONPG; Sigma – Dorset, UK) solution was added to each well. A blank of E. coli with 
ONPG without PAMAM dendrimer was used as a negative control and a vehicle control was also run 
in parallel. The production of O-nitrophenol was measured every 2 minutes for 12 minutes by 
monitoring the absorbance at 420 nm in a microplate reader (Biotek, Northstar, Bedfordshire, UK).  
 
2.4. Scanning electron microscopy of bacteria challenged with PAMAM dendrimers 
S. aureus (ATCC 11832) and E. coli (ATCC 8277) were cultured, harvested and washed as described 
above except that an overnight culture of 108 cells/mL was used to ensure that bacterial cells were 
at a sufficiently high density after the washes involved in preparation methods. 200 μL aliquots of a 
range of concentrations of each dendrimer (from 1-200 μg/mL for G2, G3 and G4-PAMAM-NH2, and 
0.0025-12.5 μg/mL for G5-PAMAM-NH2) were constituted. For G3.5-PAMAM-COOH dendrimer the 
concentration range of solutions made were between 1-250 μg/mL. The PAMAM dendrimer 
solutions (200 μL) were added to 200 μL of the bacterial inoculum and incubated at 37°C ± 1°C for 2 
hours and shaken at 200 rpm. After the incubation period the bacteria were centrifuged at 10,000 x 
g for 10 mins, resuspended in PBS (pH 7.4), centrifuged as above and the supernatant discarded. 
This was repeated 3 times to wash the harvested bacteria. The bacteria were then fixed in 2.5% 
glutaraldehyde in 0.1 M sodium cacodylate buffer (pH 7.4 containing 2 mM CaCl2) for 2 hours on a 
low speed rotator. 
 
Fixative was washed from the bacteria in sodium cacodylate buffer (pH 7.4 containing 2 mM CaCl2) 3 
times. A 100 μL aliquot of each fixed sample was added to a poly-L-lysine coated cover slip. The 
bacteria on the poly-L-lysine coated cover slips were then post-fixed in a solution of 1% sodium 
tetroxide in sodium cacodylate buffer. After a 1 hour contact time the osmium tetroxide was 
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removed by washing the cover slips in sodium cacodylate buffer (pH 7.4 containing 2 mM CaCl2). The 
cover slips were then submerged in 70% ethanol and dehydrated at 4oC for 6 days. The samples 
were then further dehydrated for ten minutes each in 70%, 80%, 90% and 100% ethanol. To remove 
the solvent from the samples they were critical-point dried three times to replace the 100% ethanol 
with liquid CO2 under pressure. Liquid CO2 was subsequently removed by increasing the temperature 
(to 40oC) and pressure until the CO2 vaporised. Samples were secured to a scanning electron 
microscope (SEM) stub mount, sputtered with gold and then placed in the high resolution (1.5 nm) 
field emission SEM (Hitachi, S4500). 
 
2.5. Statistical analysis of results 
Results are reported as the mean ± SEM (standard error of the mean) unless otherwise stated. All 
inner membrane permeabilisation data passed the D’Agostino and Pearson normality test (α = 0.05) 
using GraphPad Prism® version 5 (San Diego, USA). For the inner membrane permeabilisation data a 
two-way ANOVA with a Bonferroni post-test was used to compare the two variables of dendrimer 
generation and dendrimer concentration at the various time points. 
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3. Results 
 
3.1. Microdilution broth with viable count assay to determine the inhibitory concentration (MIC50). 
The inhibitory effect of PAMAM dendrimers against S. aureus and E. coli is shown in Table 1. For 50% 
inhibition of S. aureus the G2-PAMAM-NH2 dendrimer required >9 times the concentration that was 
required for the G5-PAMAM-NH2 dendrimer to exert the same effect. An increase in PAMAM 
generation from G2 to G5 showed that the MIC50 (S. aureus) decreased substantially (Table 1). For 
the lowest concentrations of G2-PAMAM-NH2 and G5-PAMAM-NH2 tested, bacterial growth was 
observed when compared to the untreated growth control. The MIC50 required to inhibit 50% of the 
S. aureus was approximately 2-fold higher than the concentration required to inhibit 50% of the E. 
coli. When challenged with S. aureus the carboxyl-terminated dendrimer resulted in minimal 
inhibition (Table 1). The MIC50 against S. aureus decreased with increasing numbers of surface amine 
groups on the PAMAM dendrimer (Figure 1). An exponential inhibition curve was added to the graph 
which highlights the exponential increase in molecular weight and the number of amine surface 
groups with increasing PAMAM generation. 
 
3.2. Membrane integrity study 
Figure 2 indicates that, for all three bacterial strains, the absorbance at 260 nm increased with time 
with a plateau at 80 minutes (for S. aureus) and 100 minutes for both S. epidermidis and E. coli, 
respectively. The absorbance increase for S. aureus shows a linear trend to a plateau with data 
overlapping with the control up to 40 minutes , whereas with the absorbance for S. epidermidis 
increased monotonically up to a plateau at 100 minutes. E. coli showed an increase in absorbance 
over the first 60 minutes. 
 
3.3. Inner membrane permeabilisation assay 
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In the inner membrane permeabilisation assay it was found that the absorbance reached a plateau 
at around 20 minutes. The mean absorbance at 420 nm for G2-PAMAM-NH2, G3-PAMAM-NH2, G4-
PAMAM-NH2, and G5-PAMAM-NH2 was 0.222 (95% CI: 0.221-0.224) 0.228 (95% CI: 0.227-0.230), 
0.228 (95% CI: 0.226-0.229) and 0.214 (95% CI: 0.213-0.216), respectively. A clear effect of 
concentration dependency on the inner membrane permeabilisation was observed when the vehicle 
control was compared to 5 μg/mL,when the concentrations 0.1 and 1.0 μg/mL of dendrimers were 
compared, there was no statistical difference (p>0.05). The inner membrane permeabilisation and 
thus production of O-nitrophenol, increased with increasing concentrations of the PAMAM 
dendrimer and with time (Figure 3). For all four PAMAM-NH2 dendrimer generations tested, a 
concentration as low as 5 μg/mL resulted in permeabilisation of the inner membrane by 12 minutes 
(Figure 3). The production of O-nitrophenol varied across the four PAMAM generations tested. The 
highest concentration tested (50 μg/mL) demonstrated the greatest increase in absorbance, 
therefore inducing the highest degree of inner membrane permeabilisation. However, the exception 
to this was the G5-PAMAM-NH2 dendrimer. At a particular time point of 4-10 minutes, 25 μg/mL 
solution of G5-PAMAM-NH2 dendrimer showed a higher absorbance at 420 nm and thus O-
nitrophenol production than at a 50 μg/mL concentration. G5-PAMAM-NH2 dendrimer also 
demonstrated a longer lag period for absorbance increase at 420 nm due to its high molecular 
weight and diameter causing slow passive diffusion across the cell wall and membrane. At a 
concentration of 5 μg/mL and based on the mean across all time points for a specific concentration, 
the order from the highest absorbance and thus production of o-nitrophenol to the lowest was 
G2>G3>G5>G4.   At a higher dendrimer concentration of 50 μg/mL the absorbance measurement 
trend in decreasing order was G3>G4>G2>G5. 
 
A final measurement of O-nitrophenol production was taken at 60 minutes (Figure 4). It was 
established that even after 60 minutes no change in absorbance was observed for concentrations 
below 5 μg/mL (p>0.05).  With the exception of 0.1 and 1 μg/mL of PAMAM dendrimer, there was a 
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significant difference in absorbance when comparing all concentrations of each PAMAM generation 
to the vehicle control (p<0.001).. A generation effect was also observed, to a degree, when 
comparing the absorbance at 420 nm of various PAMAM dendrimer generations over 12 minutes at 
50 µg/mL  (Figure 5).  
 
3.4. Scanning electron microscopy of bacteria challenged with PAMAM dendrimers 
Figure 6 (a-b) shows an electron micrograph of S. aureus bacteria. When compared to the G3-
PAMAM-NH2 at a concentration of 5 times the MIC50 (μg/mL), varying degrees of membrane 
damage was observed from minor blebbing through to total destruction of the cell membrane and 
cell wall (Figure 6 (c-d)). This was also found to be the case with G2-PAMAM-NH2 (Figure 6 (e-f)) and 
G5-PAMAM-NH2 (Figure 6 (g-h)). The SEM images demonstrate the ability for G2-PAMAM-NH2 and 
G5-PAMAM-NH2 to cause severe bacterial cell membrane and cell wall damage, including blebbing 
of cytoplasmic contents from damaged cell , and in some cases complete cell lysis. Sheets of 
bacterial cell wall and cytoplasmic content debris can be observed in the PAMAM treated bacteria 
images (Figure 6 (a-h)). For G3.5-PAMAM-COOH at a concentration of 1 mg/mL (Figure 6 (i-j)) there 
was no difference in bacterial cell morphology or changes to the integrity of the bacterial cell 
membrane or cell wall when compared to the untreated S. aureus group. 
 
SEM images were also collected for the Gram-negative, rod-shaped E. coli bacteria. Figure 7 (a-b) 
shows the intact PAMAM untreated group micrographs. Figure 7(c-d) illustrates the G3-PAMAM-NH2 
treated group. Damage to the bacterial wall and cell membranes can be observed due to leakage of 
the cytoplasmic contents from the cell and blebbing. The PAMAM dendrimer typically targeted the 
polar regions of the E. coli rods, consistent to the findings observed by others35. Again, no changes in 
cell morphology were observed for the G3.5-PAMAM-COOH at a concentration of 1 mg/mL.  
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4. Discussion 
 
A clear, generation-dependent trend was observed when the MIC50 of each PAMAM generation was 
related to their respective theoretical number of surface amine groups. There was an inverse 
correlation between the MIC50 concentration and PAMAM dendrimer generation. It was found that 
by increasing the number of amine groups on the dendrimer surface the concentration required to 
inhibit 50% of the bacteria dramatically decreased. Enhanced destabilization of bacterial membranes 
has been observed by increasing the number of amino groups on a polycation17. This generation-
dependent trend was contrary to the findings elsewhere15 where it was observed that the MIC for 
G3-PAMAM-NH2 and G5-PAMAM-NH2 against S. aureus was identical. A distinction in MIC value was 
found for two different PAMAM generations against P. aeruginosa as G3-PAMAM-NH2 and G5-
PAMAM-NH2 exhibited a MIC of 6.3 μg/mL and 12.5 μg/mL, respectively. The authors suggest the 
difference is due to the G3-PAMAM-NH2 dendrimer’s ability to penetrate the cell more easily due to 
its lower molecular weight compared to G5-PAMAM-NH2. This effect was not observed in the 
present study, possibly due to differences in the chemical nature of the G3 and G5 dendrimers used 
in our study and the study by Lopez et al., respectively15. 
 
Another apparent trend is that PAMAM dendrimers are more effective against Gram-negative 
bacteria such as E. coli., a finding echoed elsewhere14. E. coli has a very different cell wall structure 
and composition compared to the Gram positive S. aureus. The outer membrane of E. coli. consists 
of lipopolysaccharide (LPS), phospholipids and proteins18. LPS carries a high anionic charge at 
physiological pH due to the ionisable phosphoryl and carboxyl groups19. The polycationic nature of 
PAMAM dendrimers ensures high reactivity with, and affinity for, the outer membrane due to strong 
electrostatic forces. The high degree of interaction and disruption of the lipid bilayer of the outer 
membrane with the polycationic PAMAM dendrimer, reported previously14, is one possible 
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explanation for the enhanced antimicrobial efficacy observed for Gram-negative bacteria and for G5-
PAMAM-NH2 tested against P. aeruginosa. 
 
The results indicate that G3- PAMAM-NH2 causes intracellular components to leak from S. aureus, S. 
epidermidis and E. coli within approximately 20 minutes. Precipitation and coagulation of 
nucleotides has been observed for other cations20 and has potentially occurred with the 
concentration of PAMAM dendrimer. . The inner membrane consists of a complex proteome within 
a lipid bilayer. This is formed principally from phosphatidyl ethanolamine, phosphatidyl glycerol, and 
to a lesser extent cardiolipin, the latter two of which carry anionic charges21. Our results indicate 
that the polycationic PAMAM dendrimers have a strong affinity for the anionic inner membrane of E. 
coli. These novel results suggest that there are important time, concentration- and dendrimer 
generation-dependent effects on the inner membrane permeabilisation of E. coli.  
 
 
Structural and morphological changes induced by the dendrimers are shown in Figures 6 and 7. The 
S. aureus samples showed blebbing of cytoplasmic material on the cell surface that had been 
presumably extruded from a damaged cell membrane. Leaked cytoplasmic material, severe 
membrane damage and even separation of the cell membrane of the bacteria from the cell was also 
observed, caused by the different generations of PAMAM dendrimers. The degree of cell damage 
observed is consistent with previous studies of the cationic biocides polyquaternium-1 and 
myristamidopropyl dimethylamine22. Further, comparable cytoplasmic membrane damage was 
observed for S. aureus when challenged with the essential oil isolated from O. Vulgare23. Marked 
release of cytoplasmic contents was also observed for E. coli due to membrane damage inflicted by 
the G3-PAMAM-NH2 dendrimer, which is again consistent with previous findings with tea tree oil
24, 
and, in one case, with the G4-PAMAM-NH2 dendrimer
25, which resulted in rupturing of cell walls, 
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erosion of cell membranes and shrinkage of bacterial cells. Thus the SEM images herein suggest that 
the mechanism of action of PAMAM dendrimers is to target and disrupt the bacterial cell 
membrane.  
 
 
5. Conclusions 
 
This study has confirmed that the antimicrobial efficacy of native PAMAM dendrimers is dependent 
on generation, concentration and terminal functionalities. There was a strong correlation between 
membrane disruption and the determined biocidal activity, thus making it a key contributor to the 
mechanism of action. This study has shown that selection of the type of PAMAM dendrimer is 
important as their inherent antimicrobial efficacy is dependent on the physicochemical properties of 
specific dendrimers. Such correlations between structure and biocide function will allow a more 
appropriate and focused use of dendrimers in this role. Recently, for example, it was reported that 
following the pre-treatment of skin with a G3-PAMAM dendrimer, the subsequent skin permeation 
of chlorhexidine was significantly enhanced. This clearly indicates that the strategy for increasing 
antimicrobial efficacy with dendrimers is viable, either as a single treatment or in combination with 
other treatments26. G5-PAMAM-NH2 dendrimer would also be the most suitable polymer for biocidal 
applications as it shows the greatest efficacy against both Gram negative and Gram positive bacteria. 
Thus, this study clearly demonstrates the antimicrobial potential of dendrimers and that optimising 
their efficacy is based on dendrimer physicochemical properties. Through this understanding an 
informed choice may be made as to which PAMAM dendrimer to select as part of a quality-by-design 
approach to developing novel biocides. 
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Figure 1. Graph illustrating the calculated MIC50 (μg/mL) concentrations. MIC50 (μg/mL) with error bars 
representing 95% confidence intervals (n=3) against S. aureus plotted against the theoretical number 
of surface amine groups corresponding to G2-PAMAM-NH2, G3-PAMAM-NH2, G4-PAMAM-NH2 and 
G5-PAMAM-NH2 dendrimers. 
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Figure 2 Graphs illustrating the release of nuclear material from S. aureus, S. epidermidis 
and E. Coli: (a) Absorbance at 260 nm plotted against time for S. aureus challenged against 
G=3 x 5 MIC50; (b) Absorbance at 260 nm plotted against time for S. epidermidis challenged 
against G=3 x 5 MIC50; (c) Absorbance at 260 nm plotted against time for E. coli challenged 
against G=3 x 5 MIC50. All results are displayed as (n=3) mean ± standard deviation. 
Negative control was the absorbance at 260 nm for the untreated bacteria group. 
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Figure 3. Graphs illustrating the relationship between concentration, time and dendrimer 
generation on the inner membrane permeabilisation of E. coli; (a) corresponds to G2-
PAMAM-NH2 treated E. coli; (b) G3-PAMAM-NH2 treated E. coli; (c) G4-PAMAM-NH2 treated 
E. coli and (d) G5- PAMAM-NH2 treated E. coli. Vehicle control is displayed as the untreated 
control group. All results shown represent the mean ± SEM (n=3)  
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Figure 4. Graph illustrating the inner membrane permeabilisation of E. coli at 60 minutes for 
a range of dendrimer concentrations. Absorbance at 420 nm plotted against a range of 
dendrimer concentrations (0.1- 50 μg/mL) at 60 minutes. G2 corresponds to G2-PAMAM-
NH2 treated E. coli, G3 G3-PAMAM-NH2 treated E. coli, G4-PAMAM-NH2 treated E. coli and 
(c) G5-PAMAM-NH2 treated E. coli. VC corresponds to the vehicle control and is displayed 
as the untreated bacteria group control. All results shown represent the mean ± SEM (n=3). 
All PAMAM treated samples are significantly different (P<0.001) from the vehicle control for 
the concentration range 5-50 μg/mL. 
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Figure 5. Graphs illustrating the effect of dendrimer generation and time at specific 
concentrations on the inner membrane permeabilisation of E. coli. Absorbance at 420 nm 
plotted against time in minutes, (a) corresponds to each PAMAM generation at a 
concentration of 10 μg/mL challenged against E. coli and (b) PAMAM generations at a 
concentration of 50 μg/mL challenged against E. coli. VC corresponds to the vehicle control 
and was displayed as the untreated bacteria group control. All results shown represent the 
mean ± SEM (n=3). All treated sample values are significantly different (P<0.05)from the 
vehicle control with the exception of the 0.5 min time points and 2 minutes for G5 PAMAM at 
both concentrations tested. 
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Figure 6. Scanning electron micrographs of S. aureus challenged with PAMAM dendrimer. (a) 
untreated S. aureus at a magnification of x 25k, scale bar represents 1 μm. (b) untreated S. aureus at 
a magnification of x 30k, scale bar represents 1 μm. (c) S. aureus treated with G3-PAMAM-NH2 at a 
concentration of 5 x calculated IC50. Magnification x 30k and scale bar represents 1 μm. (d) S. aureus 
treated with G3-PAMAM-NH2 at a concentration of 5 x calculated IC50. Magnification x 30k and scale 
bar represents 1 μm. (e) S. aureus treated with G2-PAMAM-NH2 at a concentration of 250 μg/mL, 
magnification x 25k and scale bar represents 1 μm. (f) S. aureus treated with G2-PAMAM-NH2 at a 
concentration of 250 μg/mL, magnification x 40 k and scale bar represents 1 μm. (g) S. aureus treated 
with G5-PAMAM-NH2 at a concentration of 250 μg/mL, magnification x10k and scale bar represents 3 
μm. (h) S. aureus treated with G5-PAMAM-NH2 at a concentration of 250 μg/mL, magnification x20k 
and scale bar represents 1 μm. (i) S. aureus treated with G3.5-PAMAM-COOH at a concentration of 
1000 μg/mL, magnification x25k and scale bar represents 1 μm. (j) S. aureus treated with G3.5-
PAMAM-COOH at a concentration of 1000 μg/mL, magnification x30k and scale bar represents 1 μm. 
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Figure 7. Scanning electron micrographs of E. coli challenged with PAMAM dendrimer. (a) E. 
coli untreated magnification x 10 k scale bar scale bar represents 2 μm. (b) E. coli untreated 
magnification x 40 k scale bar scale bar represents 1.5 μm. (c) E. coli treated G3-PAMAM-
NH2 at a concentration of 5 x calculated IC50, magnification x 15 k and scale bar represents 
2 μm. (d) E. coli treated G3-PAMAM-NH2 at a concentration of 5 x calculated IC50, 
magnification x 50 k and scale bar represents 1.5 μm. (e) E. coli treated with 1000 μg/mL of 
G3.5-PAMAM-COOH magnification x 15 k scale bar 2 μm. (f) E. coli treated with 1000 μg/mL 
of G3.5-PAMAM-COOH magnification x 30 k scale bar 1.5 μm. 
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Table 1. Dendrimer physicochemical characteristics and calculated MIC50 (μg/mL) with 95% 
confidence intervals against S. aureus and E. coli.  
Bacteria PAMAM generation 
Molecular 
Weight 
(g/moL) 
No. of amine 
surface 
groups 
MIC50 (95% CI) µg/mL 
Staphylococcu
s aureus 
G2-PAMAM-NH2 3,256 16 26.77 (22.58- 31.75) 
G3-PAMAM-NH2 6,909 32 9.374 (7.88- 11.15) 
G4-PAMAM-NH2 14,215 64 5.962 (5.375- 6.614) 
G5-PAMAM-NH2 28,826 128 2.881 (2.473- 3.355) 
G3.5-PAMAM-COOH 12,927 64 > 250 
Escherichia coli G3-PAMAM-NH2 6,909 32 4.931 (4.28- 5.679) 
G3.5-PAMAM-COOH 12,927 64 >1000 
 
 
